Article info
Letter
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
- Correspondence to Eileen W Stalman, Department of Neurology and Neurophysiology, Amsterdam UMC Locatie AMC, Amsterdam, North Holland, Netherlands; e.w.stalman{at}amsterdamumc.nl
Citation
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Publication history
- Received October 12, 2022
- Accepted January 16, 2023
- First published January 31, 2023.
Online issue publication
May 11, 2023
Article Versions
- Previous version (31 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.